Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

108.17
+2.051.93%
Post-market: 108.170.00000.00%19:42 EDT
Volume:1.15M
Turnover:124.20M
Market Cap:12.28B
PE:31.98
High:108.49
Open:106.20
Low:105.91
Close:106.12
52wk High:108.49
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:0.58
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:85.53
PE(LYR):42.25

Loading ...

Oct 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jul 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities